دورية أكاديمية

A practical evidence-based approach to management of type 2 diabetes in children and young people (CYP): UK consensus

التفاصيل البيبلوغرافية
العنوان: A practical evidence-based approach to management of type 2 diabetes in children and young people (CYP): UK consensus
المؤلفون: Billy White, S. M. Ng, J. C. Agwu, T. G. Barrett, N. Birchmore, M. Kershaw, J. Drew, F. Kavvoura, J. Law, C. Moudiotis, E. Procter, P. Paul, F. Regan, P. Reilly, P. Sachdev, R. Sakremath, C. Semple, K. Sharples, M. Skae, A. Timmis, E. Williams, N. Wright, A. Soni
المصدر: BMC Medicine, Vol 22, Iss 1, Pp 1-17 (2024)
بيانات النشر: BMC, 2024.
سنة النشر: 2024
المجموعة: LCC:Medicine
مصطلحات موضوعية: Type 2 diabetes, Children and young people, Complications of excess weight, Metformin, Physical activity, Bariatric surgery, Medicine
الوصف: Abstract Background Type 2 diabetes in young people is an aggressive disease with a greater risk of complications leading to increased morbidity and mortality during the most productive years of life. Prevalence in the UK and globally is rising yet experience in managing this condition is limited. There are no consensus guidelines in the UK for the assessment and management of paediatric type 2 diabetes. Methods Multidisciplinary professionals from The Association of Children’s Diabetes Clinicians (ACDC) and the National Type 2 Diabetes Working Group reviewed the evidence base and made recommendations using the Grading Of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Results and discussion Young people with type 2 diabetes should be managed within a paediatric diabetes team with close working with adult diabetes specialists, primary care and other paediatric specialties. Diagnosis of diabetes type can be challenging with many overlapping features. Diabetes antibodies may be needed to aid diagnosis. Co-morbidities and complications are frequently present at diagnosis and should be managed holistically. Lifestyle change and metformin are the mainstay of early treatment, with some needing additional basal insulin. GLP1 agonists should be used as second-line agents once early ketosis and symptoms are controlled. Glycaemic control improves microvascular but not cardiovascular risk. Reduction in excess adiposity, smoking prevention, increased physical activity and reduction of hypertension and dyslipidaemia are essential to reduce major adverse cardiovascular events. Conclusions This evidence-based guideline aims to provide a practical approach in managing this condition in the UK.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1741-7015
العلاقة: https://doaj.org/toc/1741-7015Test
DOI: 10.1186/s12916-024-03349-4
الوصول الحر: https://doaj.org/article/332104656f7d4c2080092ed78a00c390Test
رقم الانضمام: edsdoj.332104656f7d4c2080092ed78a00c390
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:17417015
DOI:10.1186/s12916-024-03349-4